Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain zaps may help Parkinson's patients walk better

NCT ID NCT07190235

Not yet recruiting Symptom relief Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) can improve walking in people with Parkinson's disease. 81 participants with mild to moderate Parkinson's who have trouble starting to walk will receive 10 sessions over 2 weeks. The researchers will measure changes in balance and walking speed to see if the treatment helps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
repetitive transcranial magnetic stimulation (rTMS)
What this could lead to
If it works, this could point toward a non-invasive way to improve walking and reduce freezing episodes in people with Parkinson's disease.
What could go wrong
This is a small, early-stage trial testing a device, not a drug. The effect may be small or temporary, and not all participants may benefit. There is also a risk of discomfort or headache from the stimulation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE (DISORDER)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • The Hong Kong Polytechnic University

    Kowloon, 000000, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.